Use of statins and risk of fractures

Tjeerd-Pieter Van Staa, Sebastiaan Wegman, Frank De Vries, Bert Leufkens, Cyrus Cooper
2001-04-11
Abstract:ContextPrevious studies have reported lower fracture risks in patients taking 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).ObjectiveTo investigate risk of fracture among statin users.DesignCase-control study of data from the General Practice Research Database (GPRD).SettingA total of 683 general clinical practices in the United Kingdom.PatientsCases were 81 880 patients aged 50 years or older who had a fracture of the vertebrae, clavicle, humerus, radius/ulna, carpus, hip, ankle, or foot occurring between the enrollment date of their practice into the GPRD and July 1999, paired with 81 880 age-, sex-, and practice-matched controls.Main Outcome MeasureRisk of fracture in current users vs nonusers of statins. Odds ratios were estimated from conditional logistic regression and adjusted for smoking, medications and illnesses associated with fracture risk, and body mass index when known …
What problem does this paper attempt to address?